The Truth About The Flu Shot "By 1853, Parliament began passing laws to make the untested vaccine compulsory throughout the British Empire. Other countries of Europe followed suit. Once the economic implications of compulsory vaccinations were realized, few dared to disagree. … [Read more...] about Flu Vaccine Fact Sheet
Archives for June 2009
FDA Has Issued Emergency Use Authorizations for Two Antiviral Treatments — Tamiflu (oseltamavir) and Relenza (zanamivir)
Stockpiled Antivirals at or Nearing ExpirationDuring this public health emergency, the FDA has issued Emergency Use Authorizations that expand access to medical products that may become necessary. Two antiviral treatments covered by Emergency Use Authorizations, Tamiflu … [Read more...] about FDA Has Issued Emergency Use Authorizations for Two Antiviral Treatments — Tamiflu (oseltamavir) and Relenza (zanamivir)
FDA Safety Information and Adverse Event Reporting Program
MedWatch Online Voluntary Reporting Form (3500) Click the BEGIN button to report serious adverse events for human medical products, including potential and actual product use errors and product quality problems associated with the use of: FDA-regulated drugs, biologics … [Read more...] about FDA Safety Information and Adverse Event Reporting Program
FDA Produces 2009H1N1 Frequently Asked Quesations
FDA Press Release 2009 H1N1 Flu Virus and Antivirals Questions and Answers Q: Do the FDA’s Emergency Use Authorizations for antiviral drugs (Tamiflu and Relenza) cover their use for both prevention and treatment? The EUAs for Tamiflu and Relenza cover the emergency use of the … [Read more...] about FDA Produces 2009H1N1 Frequently Asked Quesations
FDA is Finally Prosecuting Off-Lable Marketing of Pharmaceuticals
The United States Attorney's Office District of Massachusetts FOR IMMEDIATE RELEASE JUNE 18, 2009 WWW.USDOJ.GOV/USAO/MA CONTACT: CHRISTINA DiIORIO-STERLING PHONE: (617)748-3356 E-MAIL: USAMA.MEDIA@USDOJ.GOV PHARMACEUTICAL COMPANY MANAGER SENTENCED FOR OFF-LABEL … [Read more...] about FDA is Finally Prosecuting Off-Lable Marketing of Pharmaceuticals